Organometallic Ligands

Fluvoxamine is a selective serotonin reuptake inhibitor that is used in the treatment of depression and obsessive-compulsive disorder. It blocks the reuptake of serotonin, enhancing its effects.

PXS 4728A is a small-molecule compound, which is derived from natural plant sources, acting as an activator of the sirtuin 6 (SIRT6) protein. SIRT6 is a member of the sirtuin family of NAD+-dependent deacetylases and ADP-ribosyltransferases, known to play a critical role in regulating metabolic processes, inflammation, and aging.

Potent inhibitor of dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) with IC50 value of 0.7 nM. Elevates hemoglobin and platelet levels in anemic mice.

5-HT2A/C serotonin receptor antagonist; anti-migraine agent; anti-histaminic

Alfuzosin is an alpha-1 adrenoreceptor antagonist drug that is used in treatment and management of benign prostatic hyperplasia. This drug works by relaxing the muscles in the prostate and bladder neck which results in symptom improvement.

(S)-2-Amino-3-(methylamino)propanoic acid hydrochloride is a synthetic compound often used in scientific research. It is derived from non-proteinogenic amino acids and has important implications for the study of neurotoxicology. This compound mimics the structural properties of certain naturally occurring amino acids, which allows it to act as a significant tool for understanding biological pathways affected by neurotoxins.

TP-434 2HCl is a hydrochloride salt form of a novel synthetic compound. It is synthesized through a complex organic chemical process, exploiting cutting-edge methodologies to ensure high purity and effectiveness. The compound acts primarily by inhibiting specific bacterial enzymes critical to bacterial replication and survival, thereby exhibiting potent antimicrobial properties.

Parecoxib is a COX-2 inhibitor and belongs to the group of pharmacological agents. It is a prodrug of valdecoxib that is used for the treatment of osteoarthritis and rheumatoid arthritis, as well as other conditions where the reduction in pain and inflammation are desired.

SKF-96365 is a synthetic compound known as a non-selective calcium entry blocker, which is derived from pharmacological research into ion channel modulation. Its primary mode of action involves inhibiting receptor-mediated calcium entry into cells, making it a valuable tool for scientists studying ion channel functions, especially those related to the transient receptor potential (TRP) channels.

Activator of RET signalling cascade and a derivative of a GFL mimetic compound BT 13. Molecular docking calculations and molecular dynamics simulations were performed in GDNF−GFRα1−RetA complex and showed that BT 18 binds to the allosteric site in GFRα1 as well as RetA surface interfacing GFRα1.

Inhibits lysophosphatidylserine hydrolysis by the integral membrane serine hydrolase ABHD12 (IC50 = 1.3 µM). Raised levels of lysophosphatidylserine were observed in mouse brain in vivo and in primary human macrophages. DO 264 had proinflammatory effects, following infection with lymphocytic choriomeningitis virus (LCV) clone 13 in mice, resulting in severe inflammatory lung damage.

Ciprofibrate is a fibrate drug that is used as a lipid-lowering agent. This drug reduces both LDL and VLDL cholesterol levels in the blood. Ciprofibrate works by reducing the production of triglycerides in the liver and increasing the removal of triglycerides from the blood. This drug is an agonist of peroxisome proliferator-activated receptor alpha.

Nafamostat is a broad-spectrum serine protease inhibitor produced by chemical synthesis. Nafamostat is effective through its antioxidant and anti-inflammatory activity. This drug is involved in inhibiting various enzyme systems such as coagulation and fibrinolytic systems.

Inhibits Jak kinases; immunosuppressive; anti-inflammatory

Promestriene is a synthetic estrogen derivative, which is sourced from modifications of the natural hormone estradiol. It functions by binding to estrogen receptors, primarily focusing on the mucosal and epithelial tissues. This interaction stimulates cellular proliferation and increases the thickness of the epithelial layers, thereby promoting tissue regeneration and hydration.

Gonadotropin-releasing hormone agonist

D1-like dopamine receptor agonist